Springbok Capital Management »

Protalix Biotherapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $111k 50k 2.22
2025-06-30 $83k 56k 1.48